Cargando…

Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a life-threatening drug-induced hypersensitivity reaction that is most closely associated with antiepileptics and antibiotics. While cases of DRESS are rare, here we present a case of DRESS in an adult male following administration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Syed Farrukh, Zafar, Meer R, Miller, Timothy W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098409/
https://www.ncbi.nlm.nih.gov/pubmed/32231894
http://dx.doi.org/10.7759/cureus.7098
_version_ 1783511175431979008
author Mustafa, Syed Farrukh
Zafar, Meer R
Miller, Timothy W
author_facet Mustafa, Syed Farrukh
Zafar, Meer R
Miller, Timothy W
author_sort Mustafa, Syed Farrukh
collection PubMed
description Drug reaction with eosinophilia and systemic symptoms (DRESS) is a life-threatening drug-induced hypersensitivity reaction that is most closely associated with antiepileptics and antibiotics. While cases of DRESS are rare, here we present a case of DRESS in an adult male following administration of rosuvastatin who presented with fevers, generalized rash, and facial fullness. Vitals on presentation were temperature 102(o)F, pulse 95/min, blood pressure 95/47 mmHg, and respiratory rate of 14/min. His physical examination revealed scleral icterus, generalized blanching maculopapular rash, facial fullness, and right upper quadrant tenderness. Laboratory investigations found hemoglobin 10 gm/dl, white blood cell count 16.0 K/uL, peripheral eosinophil count 1,700 K/uL, alkaline phosphatase 2,501 U/L, aspartate transaminase 620 U/L, alanine transaminase 680 U/L, total bilirubin 13.2 mg/dl with a direct component of 9 mg/dl, blood urea nitrogen 66 mg/dl, creatinine 5.20 mg/dl, glomerular filtration rate 8 ml/min, and immunoglobulin E level 623 IU/mL. Serology for viral hepatitis, Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 was negative. Computed tomographic scan of chest, abdomen, and pelvis showed generalized lymphadenopathy. Over the next week, the patient deteriorated clinically with worsening transaminitis and oliguric acute renal failure requiring renal replacement therapy. As per the European Registry of Severe Cutaneous Adverse Reaction Criteria (RegiSCAR), the probability of rosuvastatin-induced DRESS syndrome was scored as “definite.” He was treated with systemic and topical glucocorticoids leading to a gradual improvement in his symptoms. Skin biopsy was suggestive of DRESS syndrome as well. Since DRESS carries such a significant risk of mortality between 10% and 20%, DRESS must be recognized and treated as soon as symptoms present. Clinicians should also be aware that statins, one of the most commonly prescribed drugs, are also a potential cause DRESS.
format Online
Article
Text
id pubmed-7098409
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70984092020-03-30 Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms Mustafa, Syed Farrukh Zafar, Meer R Miller, Timothy W Cureus Internal Medicine Drug reaction with eosinophilia and systemic symptoms (DRESS) is a life-threatening drug-induced hypersensitivity reaction that is most closely associated with antiepileptics and antibiotics. While cases of DRESS are rare, here we present a case of DRESS in an adult male following administration of rosuvastatin who presented with fevers, generalized rash, and facial fullness. Vitals on presentation were temperature 102(o)F, pulse 95/min, blood pressure 95/47 mmHg, and respiratory rate of 14/min. His physical examination revealed scleral icterus, generalized blanching maculopapular rash, facial fullness, and right upper quadrant tenderness. Laboratory investigations found hemoglobin 10 gm/dl, white blood cell count 16.0 K/uL, peripheral eosinophil count 1,700 K/uL, alkaline phosphatase 2,501 U/L, aspartate transaminase 620 U/L, alanine transaminase 680 U/L, total bilirubin 13.2 mg/dl with a direct component of 9 mg/dl, blood urea nitrogen 66 mg/dl, creatinine 5.20 mg/dl, glomerular filtration rate 8 ml/min, and immunoglobulin E level 623 IU/mL. Serology for viral hepatitis, Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 was negative. Computed tomographic scan of chest, abdomen, and pelvis showed generalized lymphadenopathy. Over the next week, the patient deteriorated clinically with worsening transaminitis and oliguric acute renal failure requiring renal replacement therapy. As per the European Registry of Severe Cutaneous Adverse Reaction Criteria (RegiSCAR), the probability of rosuvastatin-induced DRESS syndrome was scored as “definite.” He was treated with systemic and topical glucocorticoids leading to a gradual improvement in his symptoms. Skin biopsy was suggestive of DRESS syndrome as well. Since DRESS carries such a significant risk of mortality between 10% and 20%, DRESS must be recognized and treated as soon as symptoms present. Clinicians should also be aware that statins, one of the most commonly prescribed drugs, are also a potential cause DRESS. Cureus 2020-02-25 /pmc/articles/PMC7098409/ /pubmed/32231894 http://dx.doi.org/10.7759/cureus.7098 Text en Copyright © 2020, Mustafa et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Mustafa, Syed Farrukh
Zafar, Meer R
Miller, Timothy W
Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title_full Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title_fullStr Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title_full_unstemmed Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title_short Rosuvastatin Use Implicated in the Drug Reaction with Eosinophilia and Systemic Symptoms
title_sort rosuvastatin use implicated in the drug reaction with eosinophilia and systemic symptoms
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098409/
https://www.ncbi.nlm.nih.gov/pubmed/32231894
http://dx.doi.org/10.7759/cureus.7098
work_keys_str_mv AT mustafasyedfarrukh rosuvastatinuseimplicatedinthedrugreactionwitheosinophiliaandsystemicsymptoms
AT zafarmeerr rosuvastatinuseimplicatedinthedrugreactionwitheosinophiliaandsystemicsymptoms
AT millertimothyw rosuvastatinuseimplicatedinthedrugreactionwitheosinophiliaandsystemicsymptoms